TP53 and cancer: The oligomerization domains of p63 and p73 can form mixed tetramers, suggesting functional cross talk, whereas p53 does not form heterotetramers with its family members.17,18,20 Some p53 cancer mutants possess oncogenic gain of function via interaction with p63 and p73 despite the tetramerization domains not interacting with each other.